beta-lactamase inhibitor
Showing 1 - 25 of >10,000
Sepsis, Septic Shock Trial (Piperacillin/tazobactam or temocillin, Meropenem)
Not yet recruiting
- Sepsis
- Septic Shock
- Piperacillin/tazobactam or temocillin
- Meropenem
- (no location specified)
Oct 3, 2022
Extended Spectrum Beta Lactamase Producing Organisms In Urinary
Not yet recruiting
- Urinary Tract Infections
- (no location specified)
Nov 18, 2021
Bacterial Infections Trial in Adelaide (QPX2015, Placebo oral capsule)
Completed
- Bacterial Infections
- QPX2015
- Placebo oral capsule
-
Adelaide, South Australia, AustraliaCMAX
Oct 6, 2022
Adenocarcinoma Esophagus, Locally Advanced Adenocarcinoma, Siewert Type I Adenocarcinoma of Esophagogastric Junction Trial
Not yet recruiting
- Adenocarcinoma Esophagus
- +3 more
- Vactosertib
- +2 more
- (no location specified)
Sep 13, 2023
Advancing Age and Mortality at 30 Days in Bacteremia E. Coli
Completed
- Beta-lactamase Extended Spectrum, E. Coli, Elderly, Mortality, Risk Factor
-
Nantes, FranceCHU Nantes
Sep 20, 2021
Bronchiectasis Trial in Guangzhou (Fluroquinolones, Beta-lactamase inhibitor)
Recruiting
- Bronchiectasis
- Fluroquinolones
- Beta-lactamase inhibitor
-
Guangzhou, Guangdong, ChinaState Key Laboratory of Respiratory Disease, First Affiliated Ho
Feb 8, 2020
Developing Microbials to Fight Extended-spectrum
Active, not recruiting
- Extended Spectrum Beta Lactamases (ESBL) E. Coli
- examination of stool sample
- +2 more
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Clinical Microbiology
Aug 3, 2021
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +4 more
- Biopsy
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 14, 2023
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023
Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (GSK2636771, Pembrolizumab)
Active, not recruiting
- Melanoma and Other Malignant Neoplasms of Skin
- Metastatic Melanoma
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 22, 2022
Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in Houston
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +2 more
- Anti-TGF-beta Monoclonal Antibody SAR-439459
- Cemiplimab
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2022
Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten)
Not yet recruiting
- Bacterial Infections
- Xeruborbactam Oral Prodrug
- Ceftibuten
- (no location specified)
Nov 27, 2023
Type 2 Diabetes in Obese, Obesity, Type2Diabetes Trial in San Diego (SPI-62, Cortisone-d8)
Completed
- Type 2 Diabetes Mellitus in Obese
- +2 more
-
Chula Vista, CaliforniaProSciento
Jan 26, 2023
Bacterial Infections Trial (Xeruborbactam Oral Prodrug, Ceftibuten, Xeruborbactam Oral Prodrug Placebo)
Not yet recruiting
- Bacterial Infections
- Xeruborbactam Oral Prodrug
- +3 more
- (no location specified)
Oct 6, 2023
Research of Consequences on Digestive Tract Following Proposed
Recruiting
- Urinary Tract Infections
- Urinary Tract Infections in Children
- Amikacin
- usual antibiotic treatment
-
Clamart, Ile-de France, France
- +19 more
Jan 25, 2023
Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)
Recruiting
- Acute Myeloid Leukemia
- Biospecimen Collection
- +5 more
-
Buffalo, New York
- +1 more
Jan 27, 2023
Bacteremia Caused by Gram-Negative Bacteria Trial in Worldwide (Ceftolozane-Tazobactam, Meropenem)
Withdrawn
- Bacteremia Caused by Gram-Negative Bacteria
-
Newcastle, New South Wales, Australia
- +28 more
May 17, 2022
Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +
Recruiting
- Myocardial Infarction
- +2 more
- P2Y12 Potent Inhibitor + Aspirin for STEMI patients
- Clopidogrel + Aspirin for CCS patients
-
Messina, ItalyAOU Policlinico G. Martino
Jan 21, 2023
Liver Cirrhosis Trial in Bunkyo-Ku (OP-724)
Active, not recruiting
- Liver Cirrhosis
-
Bunkyo-Ku, Tokyo, JapanTokyo Metropolitan Komagome Hospital
Jul 7, 2022
Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11
Recruiting
- Advanced Solid Tumor
- +24 more
- MDNA11 Monotherapy
- MDNA11 in combination with checkpoint inhibitor
-
Santa Monica, California
- +7 more
Nov 1, 2022